Stock Markets May 8, 2026 06:35 AM

JPMorgan Downgrade Drags Rheinmetall Shares Amid Execution and Portfolio Concerns

Analyst lowers target sharply and flags growth execution issues, product mix questions and risks from rapid deal-making

By Nina Shah

Rheinmetall shares tumbled after JPMorgan cut the stock to Neutral from Overweight and reduced its price target to €1,500 from €2,130, pointing to execution shortfalls and doubts about the company’s product mix. The downgrade followed a pair of quarterly misses in which sales and operating profit fell short of analyst consensus, and comes despite management reiterating full-year 2026 guidance and forecasting stronger growth in the second quarter.

JPMorgan Downgrade Drags Rheinmetall Shares Amid Execution and Portfolio Concerns

Key Points

  • JPMorgan downgraded Rheinmetall to Neutral from Overweight and cut its price target to €1,500 from €2,130, citing execution and product portfolio concerns.
  • Rheinmetall posted Q1 sales of €1.94 billion and operating profit of €224 million, both missing analyst consensus; the company reaffirmed full-year 2026 guidance and expects growth acceleration in Q2.
  • Analyst concerns include repeated consensus misses, questions about demand for 155mm artillery shells amid greater drone use, potential pressure on a proposed ~€80 billion contract for Boxer vehicles with KNDS, and execution risk from rapid expansion through numerous joint ventures and acquisitions.

Rheinmetall shares dropped more than 5% on Friday after JPMorgan downgraded the German defence group to Neutral from Overweight and lowered its price target to €1,500 from €2,130. The bank cited concerns about execution and the company’s product portfolio as the primary reasons for the reassessment.

The move followed a sharper decline on Thursday, when the stock fell about 7% after Rheinmetall reported first-quarter sales of €1.94 billion and operating profit of €224 million, figures that missed analyst consensus. Management nonetheless reaffirmed the company’s full-year 2026 guidance and said it expects a material acceleration in growth during the second quarter.

JPMorgan analyst David Perry acknowledged that the macro backdrop for defence spending remains constructive and that the firm still expects Rheinmetall to deliver what it described as "at least five years of strong growth." However, Perry identified two principal headwinds weighing on the shares.

First, Perry said Rheinmetall appears to be struggling to grow at the pace it desires. The analyst highlighted that the company has missed consensus estimates four times in the last six months, and warned that this trend raises the probability of earnings-per-share downgrades rather than upgrades in coming years.

Second, the analyst noted growing investor doubts about whether Rheinmetall’s product mix matches future battlefield demand. The rising prominence of drones has prompted some market participants to question the long-term market for 155mm artillery shells. Meanwhile, demand for the Boxer wheeled armoured vehicle among Germany and allied nations is significant, but Perry suggested that a proposed contract valued at roughly €80 billion - to be split equally between Rheinmetall and partner KNDS - could be at risk of being scaled back or extended over a longer time horizon.

Perry also pointed to execution risks tied to Rheinmetall’s rapid expansion strategy. Since late 2024 the company has announced at least ten new joint ventures and partnerships spanning satellites, drones, naval vessels, missiles and armoured vehicles, and it has completed three acquisitions since 2022. JPMorgan described this deal activity as "turbocharging" growth but warned that the pace may be too aggressive.

Some proposed joint ventures have taken longer than expected to finalise, the analyst said, and such delays could result in the company missing its sales targets. To account for these execution risks, JPMorgan trimmed its earnings estimates for 2027 through 2030 by 3-5% per year.


Context and immediate market impact

The downgrade and price target cut reflect JPMorgan’s view that near-term execution and portfolio questions now outweigh the favourable defence spending backdrop for Rheinmetall. The stock’s short-term weakness followed quarterly results that fell short of expectations and renewed investor focus on whether the company can deliver on an ambitious expansion agenda without compromising guidance.

Outlook

Rheinmetall maintains its full-year 2026 guidance and anticipates stronger revenue momentum in the second quarter, but JPMorgan’s notes suggest the bank foresees more downside risk to consensus earnings than upside over the medium term if execution challenges persist.

Risks

  • Execution risk from rapid expansion - numerous joint ventures and partnerships announced since late 2024 and three acquisitions since 2022 could delay revenue recognition and lead to missed sales guidance; this primarily impacts the defence manufacturing and aerospace supply sectors.
  • Product portfolio uncertainty - the growing battlefield role of drones has prompted questions about future demand for 155mm artillery shells, while large procurement contracts such as the proposed ~€80 billion Boxer vehicle agreement with KNDS could be reduced in scope or stretched out, affecting defence contractors and military procurement budgets.
  • Earnings downside - repeated consensus misses (four in the last six months) raise the likelihood of EPS downgrades rather than upgrades in coming years, influencing equity valuations in the defence sector.

More from Stock Markets

Nvidia CEO Jensen Huang Sees 27% Drop in Total Pay as Stock Awards Lose Value May 12, 2026 Activist Urges BWX Technologies to Revisit Shelved Reactor Plan, Sees Potential for Stock to Double May 12, 2026 S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026